| |
 |
Editorial [Special Board Members Issue}
 |
| |
|
pp.822-822 (1) Author: Michelle Prudhomme |
| |
|
|
| |
|
Effects of Oxymatrine from Ku Shen on Cancer Cells
|
| |
|
pp.823-826 (4) Authors: John W. Ho, Parry Lee Ngan Hon, Wai On Chim |
| |
|
|
| |
|
Titanium and Vanadium Complexes as Anticancer Agents
|
| |
|
pp.827-842 (16) Author: Irena Kostova |
| |
|
|
| |
|
Of Humans and Hamsters: The Hamster Buccal Pouch Carcinogenesis Model as a Paradigm for Oral Oncogenesis and Chemoprevention
|
| |
|
pp.843-852 (10) Author: S. Nagini |
| |
|
|
| |
|
Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia
|
| |
|
pp.853-863 (11) Authors: Manlio Tolomeo, Francesco Dieli, Nicola Gebbia, Daniele Simoni |
| |
|
|
| |
|
Synthesis, Molecular Targets, and Antitumor Activities of Substituted Tetrahydro-1- Oxopyrano[4,3-b][1]Benzopyrans and Nanogels for Drug Delivery
|
| |
|
pp.864-876 (13) Authors: Elisabeth M. Perchellet, Jean-Pierre H. Perchellet, Chanran K. Ganta, Deryl L. Troyer, Aibin Shi, Duy H. Hua |
| |
|
|
| |
|
A Novel Strategy for Advanced Pancreatic Cancer-Progression of Molecular Targeting Therapy
|
| |
|
pp.877-881 (5) Authors: Shinji Osada, Kazuhiro Yoshida |
| |
|
|
| |
|
Recent Advances in Validating MDM2 as a Cancer Target
|
| |
|
pp.882-903 (22) Authors: Elizabeth R. Rayburn, Scharri J. Ezell, Ruiwen Zhang |
| |
|
|
| |
|
Novel Anti-Prostate Cancer Curcumin Analogues That Enhance Androgen Receptor Degradation Activity
|
| |
|
pp.904-912 (9) Authors: Q. Shi, C. C.-Y. Shih, K. H. Lee |
| |
|
|
| |
|
Cytotoxic Anticancer Candidates from Terrestrial Plants
|
| |
|
pp.913-942 (30) Authors: Young-Won Chin, Kee Dong Yoon, Jinwoong Kim |
| |
|
|
